IDT Australia (ASX:IDT) Change In Receivables : A$0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 1991. Start your Free Trial

What is IDT Australia Change In Receivables?

IDT Australia's change in receivables for the quarter that ended in Jun. 2024 was A$0.00 Mil. It means IDT Australia's Accounts Receivable stayed the same from Dec. 2023 to Jun. 2024 .

IDT Australia's change in receivables for the fiscal year that ended in Jun. 2024 was A$0.00 Mil. It means IDT Australia's Accounts Receivable stayed the same from Jun. 2023 to Jun. 2024 .

IDT Australia's Accounts Receivable for the quarter that ended in Jun. 2024 was A$4.28 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. IDT Australia's Days Sales Outstanding for the six months ended in Jun. 2024 was 104.25.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. IDT Australia's liquidation value for the six months ended in Jun. 2024 was A$-2.97 Mil.

IDT Australia Change In Receivables Historical Data

The historical data trend for IDT Australia's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDT Australia Change In Receivables Chart

IDT Australia Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Receivables

Get a 7-Day Free Trial

IDT Australia Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

IDT Australia Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

IDT Australia (ASX:IDT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

IDT Australia's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4.282	/	7.496	*	91
=	104.25

2. In Ben Graham's calculation of liquidation value, IDT Australia's accounts receivable are only considered to be worth 75% of book value:

IDT Australia's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.904	-	7.93	+	0.75 * 4.282	+	0.5 * 1.681
=	-2.97

IDT Australia Change In Receivables Related Terms

Thank you for viewing the detailed overview of IDT Australia's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

IDT Australia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IDT Australia Ltd (ASX:IDT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 Wadhurst Drive, Boronia, Melbourne, VIC, AUS, 3155

Website

https://www.idtaus.com.au

IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.